Skip to main content

Gilead Sciences balance sheet

  • GILD · Nasdaq
  • Biotechnology
  • S&P 500
$168.08+0.08%Close 13 Nov 2026 · Market value $210.1B

At the end of fiscal 2025 (the year to 31 Dec 2025), Gilead Sciences reported total assets of $59.02B, $7.56B in cash and equivalents, $25.54B of total debt; shareholders' equity was $22.70B.

From Gilead Sciences's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Gilead Sciences balance sheet, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$968.1M$1.46B$1.27B$907.9M$9.88B$1.80B$2.11B$10.03B$12.85B$8.23B$7.59B$17.94B$11.63B$6.00B$5.34B$5.41B$6.08B$9.99B$7.56B
Short-term investments—$330.8M$384.0M$1.19B$16.49M$58.56M$19.00M$101.0M$1.76B$3.67B$17.92B$12.15B$12.72B$1.41B$1.18B$973.0M$1.18B$0.00$68.00M
Cash and short-term investments$968.1M$1.79B$1.66B$2.10B$9.90B$1.86B$2.13B$10.13B$14.61B$11.89B$25.51B$30.09B$24.35B$7.41B$6.52B$6.38B$7.26B$9.99B$7.63B
Accounts receivable—$1.02B$1.39B$1.62B$1.95B$1.75B$2.18B$4.63B$5.85B$4.51B$3.85B$3.33B$3.58B$4.89B$4.49B$4.78B$4.66B$4.42B$4.91B
Inventory—$927.9M$1.05B$1.20B$1.39B$1.74B$1.70B$1.39B$1.96B$1.59B$801.0M$814.0M$922.0M$1.68B$1.62B$1.51B$1.79B$1.71B$1.77B
Current assets—$4.28B$4.81B$5.71B$13.92B$6.16B$7.00B$17.71B$24.76B$19.59B$31.82B$35.84B$30.30B$16.00B$14.77B$14.44B$16.09B$19.17B$18.34B
Property, plant and equipment—$528.8M$700.0M$701.2M$774.4M$1.10B$1.17B$1.67B$2.28B$2.87B$3.29B$4.01B$4.50B$4.97B$5.12B$5.47B$5.32B$5.41B$5.61B
Goodwill——$462.6M$532.7M$1.00B$1.06B$1.17B$1.17B$1.17B$1.17B$4.16B$4.12B$4.12B$8.11B$8.33B$8.31B$8.31B$8.31B$8.31B
Acquired intangibles——$923.3M$863.4M$1.06B$11.74B$11.90B$11.07B$10.25B$8.97B$17.10B$15.74B$13.79B$33.13B$33.45B$28.89B$26.45B$19.95B$16.98B
Long-term investments—$1.45B$2.25B$3.22B$63.70M$719.8M$439.0M$1.60B$11.60B$20.48B$11.18B$1.42B$1.49B$502.0M$1.31B$1.25B$1.16B$0.00$2.97B
Total assets—$6.94B$9.70B$11.59B$17.30B$21.24B$22.58B$34.66B$51.72B$56.98B$70.28B$63.67B$61.63B$68.41B$67.95B$63.17B$62.13B$58.99B$59.02B
Accounts payable—$601.2M$810.5M$803.0M$1.21B$1.33B$1.26B$955.0M$1.18B$1.21B$814.0M$790.0M$713.0M$844.0M$705.0M$905.0M$550.0M$833.0M$715.0M
Unearned revenue, current—$42.96M$122.7M$103.2M$74.67M$103.2M$111.0M$134.0M$440.0M$202.0M—————————
Long-term debt · current portion—$5.63M$5.59M$646.3M$0.00$1.17B$2.70B$483.0M$982.0M$0.00$2.75B$2.75B$2.50B$2.76B$1.52B$2.27B$1.80B$1.81B$2.81B
Current liabilities—$1.22B$1.87B$2.46B$2.51B$4.24B$6.41B$5.76B$9.89B$9.22B$11.63B$10.61B$9.76B$11.40B$11.61B$11.24B$11.28B$12.00B$11.81B
Long-term debt · non-current—$1.10B$1.16B$3.48B$7.61B$7.05B$3.94B$11.92B$21.07B$26.35B$30.80B$24.57B$22.09B$28.64B$25.18B$22.96B$23.19B$24.90B$22.13B
Operating lease liability————————————$725.0M$715.0M$590.0M$578.0M$671.0M$611.0M$605.0M
Total liabilities—$2.47B$3.19B$5.47B$10.44B$11.69B$10.77B$18.83B$32.60B$37.61B$49.78B$42.14B$38.98B$50.19B$46.89B$41.96B$39.38B$39.75B$36.40B
Retained earnings—$300.3M$2.00B$1.18B$1.78B$3.70B$6.11B$12.73B$18.00B$18.15B$19.01B$19.02B$19.39B$14.38B$16.32B$15.69B$16.30B$11.50B$13.73B
Minority interest—$193.0M$138.1M$258.1M$128.5M$241.1M$375.0M$393.0M$579.0M$476.0M$59.00M$147.0M$125.0M$19.00M−$5.00M−$31.00M−$84.00M−$84.00M−$84.00M
Shareholders' equity$3.75B$4.27B$6.37B$5.86B$6.74B$9.30B$11.37B$15.43B$18.53B$18.89B$20.44B$21.39B$22.52B$18.20B$21.07B$21.24B$22.83B$19.33B$22.70B
Total liabilities and equity—$6.94B$9.70B$11.59B$17.30B$21.24B$22.58B$34.66B$51.72B$56.98B$70.28B$63.67B$61.63B$68.41B$67.95B$63.17B$62.13B$58.99B$59.02B
Total debt—$1.10B$1.16B$4.13B$7.61B$8.22B$6.64B$12.40B$22.05B$26.35B$33.54B$27.32B$25.32B$32.12B$27.29B$25.81B$25.66B$27.32B$25.54B
Net debt—−$686.4M−$495.9M$2.03B−$2.29B$6.36B$4.50B$2.27B$7.45B$14.45B$8.03B−$2.77B$966.0M$24.71B$20.77B$19.42B$18.39B$17.33B$17.91B
Net working capital—$1.60B$1.67B$2.34B$1.52B$114.8M−$1.52B$1.93B$2.02B$2.14B$12.60B$7.29B$8.91B−$1.40B−$2.18B−$2.21B−$1.28B−$2.82B−$1.03B
Shares outstanding · period end—1.8B1.8B1.6B1.5B1.5B1.5B1.5B1.4B1.3B1.3B1.3B1.3B1.3B1.3B1.2B1.2B1.2B1.2B

Quarterly

Gilead Sciences balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$6.08B$4.72B$2.77B$5.04B$9.99B$7.93B$5.14B$7.33B$7.56B$7.63B$3.18B$6.44B
Short-term investments$1.18B$0.00$0.00$0.00$0.00—$69.00M$19.00M$68.00M$15.00M$0.00$0.00
Cash and short-term investments$7.26B$4.72B$2.77B$5.04B$9.99B$7.93B$5.21B$7.35B$7.63B$7.64B$3.18B$6.44B
Accounts receivable$4.66B$4.67B$4.66B$4.59B$4.42B$4.39B$4.78B$5.09B$4.91B$4.74B$5.05B$5.01B
Inventory$1.79B$1.85B$2.03B$1.87B$1.71B$1.76B$1.82B$1.78B$1.77B$1.91B$1.95B$1.90B
Current assets$16.09B$14.04B$12.32B$14.78B$19.17B$16.90B$14.72B$17.87B$18.34B$18.64B$13.95B$16.55B
Property, plant and equipment$5.32B$5.32B$5.35B$5.39B$5.41B$5.42B$5.46B$5.50B$5.61B$5.64B$5.83B$5.95B
Goodwill$8.31B$8.31B$8.31B$8.31B$8.31B$8.31B$8.31B$8.31B$8.31B$8.31B$8.31B$8.31B
Acquired intangibles$26.45B$23.43B$22.83B$20.55B$19.95B$19.36B$18.57B$17.97B$16.98B$16.38B$14.03B$13.42B
Long-term investments$1.16B$0.00$0.00$0.00$0.00—$1.91B$2.00B$2.97B$983.0M$0.00$0.00
Total assets$62.13B$56.29B$53.58B$54.52B$58.99B$56.43B$55.72B$58.53B$59.02B$56.28B$49.36B$51.41B
Accounts payable$550.0M$622.0M$537.0M$903.0M$833.0M$737.0M$582.0M$808.0M$715.0M$645.0M$674.0M$934.0M
Long-term debt · current portion$1.80B$3.67B$1.81B$1.81B$1.81B$2.81B$2.81B$2.81B$2.81B$1.31B$2.41B$2.42B
Current liabilities$11.28B$13.02B$10.78B$11.72B$12.00B$12.34B$11.19B$12.30B$11.81B$9.48B$11.02B$12.00B
Long-term debt · non-current$23.19B$21.53B$21.54B$21.44B$24.90B$22.15B$22.14B$22.14B$22.13B$20.86B$23.83B$23.82B
Operating lease liability$671.0M———$611.0M———$605.0M———
Total liabilities$39.38B$38.84B$35.38B$36.13B$39.75B$37.36B$36.13B$37.08B$36.40B$32.85B$37.62B$38.45B
Retained earnings$16.30B$10.66B$11.16B$11.07B$11.50B$10.93B$11.32B$12.82B$13.73B$14.13B$2.20B$3.11B
Minority interest−$84.00M−$84.00M−$84.00M−$84.00M−$84.00M−$84.00M−$84.00M−$84.00M−$84.00M−$84.00M−$84.00M−$84.00M
Shareholders' equity$22.83B$17.54B$18.28B$18.48B$19.33B$19.16B$19.67B$21.54B$22.70B$23.52B$11.83B$13.04B
Total liabilities and equity$62.13B$56.29B$53.58B$54.52B$58.99B$56.43B$55.72B$58.53B$59.02B$56.28B$49.36B$51.41B
Total debt$25.66B$25.19B$23.35B$23.25B$27.32B$24.95B$24.95B$24.94B$25.54B$22.17B$26.25B$26.23B
Net debt$18.39B$20.48B$20.58B$18.21B$17.33B$17.03B$19.73B$17.59B$17.91B$14.53B$23.07B$19.79B
Net working capital−$1.28B−$3.69B−$1.24B−$1.98B−$2.82B−$3.37B−$1.61B−$1.75B−$1.03B$1.54B−$254.0M−$1.89B
Shares outstanding · period end1.2B1.2B1.2B1.2B1.2B1.2B1.2B1.2B1.2B1.2B1.2B1.2B

The main figures as JSON and plain text. See data and methodology.

GILD in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.